February 8, 2021
Izzo NJ et al. Alzheimer’s Dement 2021;1–18.
Preclinical and clinical biomarker studies of CT1812:
A novel approach to Alzheimer’s disease modification
Download publication
You might also be interested by
CellTalk
Landmark study on metastatic breast cancer highlights the importance of identifying HER2-low patients
June 23, 2022
Proteomics/Mass Spectrometry
More infoPress Releases
CellCarta expands it proteomics portfolio with the acquisition of next-generation immuno-MRM assays from Precision Assays
May 19, 2022
Proteomics/Mass Spectrometry
More infoBrochures
High Performance Technologies for Cytokine Measurement
November 8, 2021
Immune Monitoring
More info